HEMATOLOGY

Latest News

NCCN Guidelines Add Ropeginterferon Alfa for First-Line Polycythemia Vera
NCCN Guidelines Add Ropeginterferon Alfa for First-Line Polycythemia Vera

February 28th 2024

Ropeginterferon alfa is now a recommended first-line treatment for patients with polycythemia vera, according to the National Comprehensive Cancer Network’s updated guidelines.

Acknowledging Different Considerations for Ruxolitinib in Severe GVHD
Acknowledging Different Considerations for Ruxolitinib in Severe GVHD

February 26th 2024

Better Survival, Tolerability in Older Patients With Orca-T for Hematologic Cancers
Better Survival, Tolerability in Older Patients With Orca-T for Hematologic Cancers

February 26th 2024

Retrospective Data Show Response With Belumosudil/Ruxolitinib in cGVHD
Retrospective Data Show Response With Belumosudil/Ruxolitinib in cGVHD

February 23rd 2024

Azoles Given Alongside Ruxolitinib Does Not Impact Efficacy in Acute GVHD
Azoles Given Alongside Ruxolitinib Does Not Impact Efficacy in Acute GVHD

February 23rd 2024

More News